Median Technologies forms strategic review committee, names Oern Stuge chair
Reuters2026/09/02 15:45- Median Technologies created a Strategic Review Committee to assess structural and financial options to lift shareholder value.
- Scope includes a potential separation of iCRO from eyonis, potential U.S. listing, other strategic alternatives.
- Oern Stuge will chair the committee; the former Medtronic executive has led EMEA and emerging markets, cardiac surgery businesses.
- A new board-level R&D Committee will oversee scientific priorities and the expansion of the eyonis platform beyond lung cancer screening.
- Kapil Dhingra will chair the R&D Committee; he previously led oncology clinical development at Roche, worked at MD Anderson.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uber cuts workforce about 10% in corporate reorganization
Nvidia completes the inference loop: partners with Equinix and Together AI to open model inference to enterprises
Nvidia has partnered with Equinix, the world's largest data center colocation provider, and AI inference platform Together AI, with each party handling distinct roles—Equinix provides colocation services, Together AI offers the inference platform, and Nvidia supplies GPUs and the software stack—to jointly deliver open model inference services for enterprise clients. This move marks Nvidia's expansion of its computing ecosystem from training to inference, completing a closed-loop offering.
British Pound drops to three-week low as hawkish BoJ and suspected intervention boost Yen
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
